Rhythm Pharmaceuticals, Inc.
RYTM· Nasdaq
Released May 3, 2021, before the open
10-Q filed May 3, 2021, 33 days after period end · 0001558370-21-005475
| Metric | Q1 2021 | Q1 2020 | Q1 2019 | Q1 2018 |
|---|---|---|---|---|
| Revenue | $35.00K | — | — | — |
| Net Income | $43.75M | -$34.16M | -$28.97M | -$16.46M |
| EPS Diluted |
Rhythm Pharmaceuticals, Inc. · CIK 1649904 · Engraved from SEC EDGAR
| $0.90 |
| -$0.78 |
| -$0.84 |
| -$0.60 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.